The dangers of dextropropoxyphene

Australian and New Zealand Journal of Psychiatry

Volumn 30, Issue 6, 1996, Pages 864-866

  Dore, Glenys Marie ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b HealthCare Otago ^*  (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROPROPOXYPHENE; METHADONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DEPENDENCE; DRUG USE; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; SOCIAL PSYCHOLOGY;

EID: 0030484323     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.3109/00048679609065057     Document Type: Article

References (7)

1. King P, Coleman JH. Stimulants and narcotic drugs. Paediatric Clinics of North America 1987; 34:349-362.
2. Soumerai SB, Avorn J, Gortmaker S, Hawley S. Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene American Journal of Public Health 1987; 77:1518-1523.
3. Chambers CD, Moffett AD, Cuskey WR. Five patterns of darvon abuse. International Journal of the Addictions 1971; 6:173-189.
4. McEvoy GK et al. American Hospital Formulatory Service (AHFS) 96 drug information. Bethesda: American Society of Health-System Pharmacists, 1996.
5. Ward J, Mattick RP, Hall W. Key issues in methadone maintenance treatment. Sydney: New South Wales University Press, 1992.
6. Lawson AAH, Northridge DB. Dextropropoxyphene overdose. Epidemiology, clinical presentation and management. Toxicology Management Review 1987; 2:430-444.
7. Dukes PD, Robinson GM, Thomson KJ, Robinson BJ. Wellington coroner autopsy cases 1970-89: acute deaths due to drugs, alcohol and poisons. New Zealand Medical Journal 1992; 105:25-27.